Advancing Adolescent Bedtime by Using Motivational Interviewing and Text Reminders - A Randomized Controlled Trial
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Sleep Deprivation
- Sponsor
- Chinese University of Hong Kong
- Enrollment
- 212
- Locations
- 1
- Primary Endpoint
- Change of Sleep duration by sleep diary
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
Chronic sleep deprivation among adolescents is a prevalent health problem across the world and is associated with a series of short and long term consequences. However, effective interventions targeting on this vulnerable adolescent population is very limited. Majority of the previous sleep education programme are conducted in a school context which personal factors and individualized problems were not addressed. In addition, failure to address "knowledge-action gap" may also explain why individual fail to enact health behaviors even holding positive motivation. In regard to this, investigators proposed an active and person-oriented protocol with the aid of advanced technology in order to improve adolescent sleep health.
Detailed Description
This study will conduct a randomized control trial to evaluate the effectiveness of group-based sleep intervention using motivational interviewing plus text reminders in changing adolescent sleep deprivation problem with both subjective and objective measurements. The intervention will consists of 4 weekly group therapy targeting on adolescent with school day sleep duration less than 7 hours.
Investigators
CHAN NGAN YIN
Research Associate
Chinese University of Hong Kong
Eligibility Criteria
Inclusion Criteria
- •Chinese aged 12-18 years old
- •Written informed consent of participation into the study is given by adolescents and his/her parents;
- •Being able to comply with the study protocol;
- •Having weekday sleep duration less than 7 hours for past 1 month as reported by questionnaire and average of \<7hr weekday sleep as reported by sleep diary as an indication of chronic sleep deprivation status.
- •Possess a mobile phone
Exclusion Criteria
- •A current or past history of neuropsychiatric disorder(s);
- •A prominent medical condition or taking medication with potential side effects that may influence sleep quantity and quality
- •Having a clinical sleep disorder that may potentially contribute to the disruption of sleep quantity and quality as ascertained by both Structured Diagnostic Interview for Sleep patterns and Disorders such as insomnia, delayed sleep phase and narcolepsy.
- •have enrolled in any intervention programme that may affect their sleep patterns in the past three months or are planning to join intervention programme in the next three month
Outcomes
Primary Outcomes
Change of Sleep duration by sleep diary
Time Frame: Baseline, 1 week, 3 month and 6 month after treatment
Daily sleep diary for consecutive seven days. Sleep parameter estimated by daily sleep diary: total sleep time (TST) in hours
Change of Sleep duration by actigraphy
Time Frame: Baseline, 1 week, 3 month and 6 month after treatment
Sleep parameter estimated by actigraphy: total sleep time (TST) in hours
Secondary Outcomes
- Change of Daytime Sleepiness(Baseline, 1 week, 3 month and 6 month after treatment)
- Change of Sleep Hygiene(Baseline, 1 week, 3 month and 6 month after treatment)
- Change of objective cognitive performance (inhibitory ability)(Baseline, 3 month and 6 month after treatment)
- Change of objective cognitive performance (working memory by N-Back)(Baseline, 3 month and 6 month after treatment)
- Change of Sleep knowledge(Baseline, 1 week, 3 month and 6 month after treatment)
- Change of Anxiety and depressive symptoms(Baseline, 1 week, 3 month and 6 month after treatment)
- Change of Quality of Life(Baseline, 1 week, 3 month and 6 month after treatment)
- Change of Academic performance(Baseline, 3 month and 6 month after treatment)
- Change of objective cognitive performance (working memory by digit span)(Baseline, 3 month and 6 month after treatment)
- Change of risk-taking & decision making(Baseline, 3 month and 6 month after treatment)